Nexstim Plc (HEL:NXTMH)
Finland flag Finland · Delayed Price · Currency is EUR
13.80
0.00 (0.00%)
Jul 25, 2025, 6:23 PM EET

Nexstim Company Description

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally.

The company’s transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head.

It provides Navigated Brain Stimulation (NBS) 5 system, a TMS system for the pre-surgical mapping of the motor cortex and the speech areas of the brain; and NBS 6 and NBT, a navigated brain therapy systems for the treatment of major depressive disorder and chronic neuropathic pain.

The company markets and sells its diagnostics systems to universities and teaching hospitals. It has an exclusive collaboration with Sinaptica Therapeutics, Inc. to develop, manufacture, and supply y Sinaptica’s patented precision neuromodulation device based on the Nexstim NBS 6 medical TMS and neuronavigation systems and related software; and a development and distribution collaboration with Brainlab AG for the development of solutions for non-invasive mapping of specific parts of the brain and Brainlab’s role as a distributor for certain Nexstim products.

The company was incorporated in 2000 and is headquartered in Helsinki, Finland.

Nexstim Plc
Nexstim logo
CountryFinland
Founded2000
IndustryMedical Devices
SectorHealthcare
Employees40
CEOMikko Karvinen

Contact Details

Address:
Elimäenkatu 9 B
Helsinki, 00510
Finland
Phone358 9272 7170
Websitenexstim.com

Stock Details

Ticker SymbolNXTMH
ExchangeNasdaq Helsinki
Fiscal YearJanuary - December
Reporting CurrencyEUR
ISIN NumberFI4000506811
SIC Code3845

Key Executives

NamePosition
Mikko KarvinenChief Executive Officer
Joonas JuokslahtiChief Financial Officer
Henri HannulaChief Commercial Officer